The large volume of asylum seekers and irregular migrants entering continental Europe constitutes a public health challenge. Migrant facilities in many European Union (EU) Member States have the potential to be overwhelmed with much higher numbers of migrants than the sites were originally...

The increasing number of people entering the European Union/European Economic Area (EU/EEA) as asylum seekers and irregular migrants has challenged public health authorities to provide relevant, proportionate and appropriate services, including communicable disease-related services. As a...

The overall aim of the study is to monitor near real-time performance of COVID-19 vaccines administered as part of 2023 autumnal vaccination campaigns in the community-dwelling resident population aged ≥65 years in EU/EEA countries to detect any variation in VE, so that public health vaccine...

This protocol describes the common methodology to be applied to established health data registries across seven participating European Union/European Economic Area (EU/EEA) Member States to estimate vaccine effectiveness for Coronavirus disease 2019 (COVID-19) in children and adolescents aged...

This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses (compared to complete primary vaccination with no booster) against hospitalisation due to COVID-19 and COVID-19-related death in resident populations ≥50 years of age living...

This protocol presents a common updated methodology to estimate vaccine effectiveness (VE) for COVID-19, using established health data registries in participating European Union and European Economic Area (EU/EEA) countries. This work is performed within the Vaccine Effectiveness, Burden and...